From NAMS 2021: The truth about aspirin and statin prescription for CVD prevention
Margo B. Minissian, PhD, shares key updates from the newest recommendations for primary prevention of cardiovascular disease in women from the ACC and AHA. Minissian is executive director, Geri & Richard Brawerman Nursing Institute at Cedars-Sinai Medical Center and the Simms/ Mann Endowed Chair of Nursing Education, Innovation and Research at Cedars-Sinai Medical Center.
Cardiovascular disease (CVD) remains the leading cause of morbidity for women in the United States. Prior to the update in 2020, published in the Journal of the American College of Cardiology, there had been no formal guidelines from the American College of Cardiology (ACC)/American Heart Association (AHA) specifically addressing CVD in women since 2011.
In her presentation at the North American Menopause Society’s (NAMS) 2021 Annual Meeting, Minissian discussed the update’s critical topics related to risk factors and treatments that have led to controversies and confusion.
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
